Published in Medical Letter on the CDC and FDA, March 5th, 2006
Alprazolam extended-release tablets are the AB-rated generic equivalent of Pharmacia's and Upjohn's Xanax XR Tablets, an antianxiety drug which had U.S. sales of approximately $100 million for the 12-month period ending June 30, 2005, according to IMS Health.
This product will begin shipping immediately.
Mylan Laboratories Inc. is a pharmaceutical company with three...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.